RND3 and glioma: The RND3 deficiency-mediated glioma cell aberrant proliferation can be blocked by Notch inhibitor compound E treatment or by the knockdown of NOTCH1. Moreover, we found that the expression levels of RND3 were inversely correlated with Notch activities in human GBM tissues.